These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 24928215)

  • 21. Evaluation of greater wax moth larvae, Galleria mellonella, as a novel in vivo model for non-tuberculosis Mycobacteria infections and antibiotic treatments.
    Entwistle FM; Coote PJ
    J Med Microbiol; 2018 Apr; 67(4):585-597. PubMed ID: 29458557
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhanced efficacy of imipenem-colistin combination therapy against multiple-drug-resistant Enterobacter cloacae: in vitro activity and a Galleria mellonella model.
    Yang H; Chen G; Hu L; Liu Y; Cheng J; Ye Y; Li J
    J Microbiol Immunol Infect; 2018 Feb; 51(1):70-75. PubMed ID: 26906264
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro effects of combinations of antipseudomonal agents against seven strains of multidrug-resistant Pseudomonas aeruginosa.
    Oie S; Uematsu T; Sawa A; Mizuno H; Tomita M; Ishida S; Okano Y; Kamiya A
    J Antimicrob Chemother; 2003 Dec; 52(6):911-4. PubMed ID: 14585851
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro antibacterial activity of rifampicin in combination with imipenem, meropenem and doripenem against multidrug-resistant clinical isolates of Pseudomonas aeruginosa.
    Hu YF; Liu CP; Wang NY; Shih SC
    BMC Infect Dis; 2016 Aug; 16(1):444. PubMed ID: 27553962
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fish oils against Burkholderia and Pseudomonas aeruginosa: in vitro efficacy and their therapeutic and prophylactic effects on infected Galleria mellonella larvae.
    Mil-Homens D; Ferreira-Dias S; Fialho AM
    J Appl Microbiol; 2016 Jun; 120(6):1509-19. PubMed ID: 27012860
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro selection of resistance in Pseudomonas aeruginosa and Acinetobacter spp. by levofloxacin and ciprofloxacin alone and in combination with beta-lactams and amikacin.
    Drago L; De Vecchi E; Nicola L; Tocalli L; Gismondo MR
    J Antimicrob Chemother; 2005 Aug; 56(2):353-9. PubMed ID: 15967767
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bacteriophage-antibiotic combinations against ciprofloxacin/ceftriaxone-resistant Escherichia coli in vitro and in an experimental Galleria mellonella model.
    Wang L; Tkhilaishvili T; Bernal Andres B; Trampuz A; Gonzalez Moreno M
    Int J Antimicrob Agents; 2020 Dec; 56(6):106200. PubMed ID: 33075514
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of in vitro critical inhibitory concentration, a novel approach to predict in vivo synergistic bactericidal effect of combined amikacin and piperacillin against Pseudomonas aeruginosa in a systemic rat infection model.
    Chan E; Zhou S; Srikumar S; Duan W
    Pharm Res; 2006 Apr; 23(4):729-41. PubMed ID: 16554956
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro synergistic effect of ciprofloxacin with aminoglycosides against multidrug resistant-Pseudomonas aeruginosa.
    Yasmin F; Akhtar N; Hameed A
    Pak J Pharm Sci; 2013 Sep; 26(5):1041-4. PubMed ID: 24035966
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In-vitro effects of a combination of antipseudomonal antibiotics against multi-drug resistant Pseudomonas aeruginosa.
    Oie S; Sawa A; Kamiya A; Mizuno H
    J Antimicrob Chemother; 1999 Nov; 44(5):689-91. PubMed ID: 10552987
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human breast milk isolated lactic acid bacteria: antimicrobial and immunomodulatory activity on the
    Guarnieri A; Venditti N; Cutuli MA; Brancazio N; Salvatore G; Magnifico I; Pietrangelo L; Falcone M; Vergalito F; Nicolosi D; Scarsella F; Davinelli S; Scapagnini G; Petronio Petronio G; Di Marco R
    Front Cell Infect Microbiol; 2024; 14():1428525. PubMed ID: 39310784
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Carbapenem-Only Combination Therapy against Multi-Drug Resistant
    Mackay B; Parcell BJ; Shirran SL; Coote PJ
    Antibiotics (Basel); 2022 Oct; 11(11):. PubMed ID: 36358122
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vivo activity of vancomycin combined with colistin against multidrug-resistant strains of Acinetobacter baumannii in a Galleria mellonella model.
    Yang H; Lv N; Hu L; Liu Y; Cheng J; Ye Y; Li J
    Infect Dis (Lond); 2016; 48(3):189-94. PubMed ID: 26503239
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Establishment and Validation of Galleria mellonella as a Novel Model Organism To Study Mycobacterium abscessus Infection, Pathogenesis, and Treatment.
    Meir M; Grosfeld T; Barkan D
    Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29437630
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Species-specific activity of antibacterial drug combinations.
    Brochado AR; Telzerow A; Bobonis J; Banzhaf M; Mateus A; Selkrig J; Huth E; Bassler S; Zamarreño Beas J; Zietek M; Ng N; Foerster S; Ezraty B; Py B; Barras F; Savitski MM; Bork P; Göttig S; Typas A
    Nature; 2018 Jul; 559(7713):259-263. PubMed ID: 29973719
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [In vitro combined effects of double antibacterial drugs against multidrug-resistant Pseudomonas aeruginosa isolates: comparison among combinations of colistin, arbekacin, aztreonam, rifampicin and piperacillin].
    Nagaoka R; Ikawa K; Onodera M; Koba Y; Hara T; Joichi Y; Yokozaki M; Ohge H; Morikawa N
    Jpn J Antibiot; 2014 Jun; 67(3):167-74. PubMed ID: 25163250
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vivo activity of co-trimoxazole combined with colistin against Acinetobacter baumannii producing OXA-23 in a Galleria mellonella model.
    Khalil MAF; Moawad SS; Hefzy EM
    J Med Microbiol; 2019 Jan; 68(1):52-59. PubMed ID: 30422109
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Pseudomonas aeruginosa bacteremia: associations with a source of infection and antibiotic resistance].
    Dambrauskiene A; Adukauskiene D; Jeroch J; Vitkauskiene A
    Medicina (Kaunas); 2009; 45(1):1-7. PubMed ID: 19223699
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of Antibiotic Combinations against Multidrug-Resistant Pseudomonas aeruginosa in Automated Time-Lapse Microscopy and Static Time-Kill Experiments.
    Olsson A; Wistrand-Yuen P; Nielsen EI; Friberg LE; Sandegren L; Lagerbäck P; Tängdén T
    Antimicrob Agents Chemother; 2020 May; 64(6):. PubMed ID: 32179531
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aminoglycosides plus beta-lactams against gram-negative organisms. Evaluation of in vitro synergy and chemical interactions.
    Giamarellou H
    Am J Med; 1986 Jun; 80(6B):126-37. PubMed ID: 3088998
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.